3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
29
Pain, Postoperative
10
Colorectal Neoplasms
10
Neoplasms
8
Brain Neoplasms
8
Stomach Neoplasms
7
Prostatic Neoplasms
6
Lung Neoplasms
6
Pancreatic Neoplasms
5
Melanoma
5
Ovarian Neoplasms
4
Hemorrhage
4
Head and Neck Neoplasms
4
Agnosia
4
Rectal Neoplasms
3
Neurotoxicity Syndromes
3
Nasopharyngeal Carcinoma
3
Myoma
3
Multiple Endocrine Neoplasia Type 1
3
Meningioma
3
Lymphoma, Non-Hodgkin
3
Leiomyoma
3
Glioblastoma
3
Delirium
3
Colonic Neoplasms
3
Chronic Pain
3
Warts
2
Uterine Cervical Neoplasms
2
Stomatitis
2
Skin Neoplasms
2
Interventions
Temozolomide
109
Magnetic Resonance Spectroscopy
52
Bevacizumab
52
Radiotherapy
44
Irinotecan
27
Blood Specimen Collection
19
Surgical Procedures, Operative
16
Radiation
15
Aminolevulinic Acid
15
Carboplatin
13
fluorodopa F 18
12
Nivolumab
12
Radiotherapy, Intensity-Modulated
11
Carmustine
11
Radiosurgery
10
Magnetic Resonance Imaging
10
pembrolizumab
9
Topotecan
9
Specimen Handling
9
Everolimus
9
Erlotinib Hydrochloride
9
Biopsy
9
poly ICLC
8
Surveys and Questionnaires
8
Standard of Care
8
Etoposide
8
Drug Therapy
8
Lomustine
7
Filgrastim
7
Cyclophosphamide
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Glioma
×
Sodium Chloride
×
Clear all
NCT02465268
2025-01-14
ATTAC-II
University of Florida
Phase 2
Completed
175 enrolled
18 charts